Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    News Scan

    Biodefense Headlines – November 2, 2014

    By Global Biodefense StaffNovember 2, 2014
    Share
    Facebook LinkedIn Reddit Email

    Troops to be checked for chemical exposure in Iraq | Aerosolized fungal infection from bats | Recommendations regarding Ebola response | EVD-68 cases fading, but more unexplained neuro illnesses | Evaluation of border entry screening for infectious diseases in humans | FDA approves vaccine for a rare meningitis | Ebola: Failures of imagination | The decision to publish an avian H7N1 gain-of-function experiment | Novel biosensor could allow rapid detection of Ebola virus | BARDA: The venture capital firm buried in the U.S. government | Drug that lost high-stakes political fight for funding now being used against Ebola | Better staffing seen as crucial to Ebola treatment in Africa | Light frequencies help sniff out deadly materials from a distance | Ebola genome browser now online to aid researchers | The bad, the worse and the over-interpreted | CSL-Novartis deal includes US cell-based flu vaccine plant | Joint Chiefs chairman urges 21-day quarantine for troops in Ebola zone | “Airborne” Ebola: A review of the issue | Mandatory Ebola quarantine is about politics, not public health | WHO updates Ebola PPE guidance for health providers | Army providing communications backbone for Ebola response

    See what we’re reading this week at Global Biodefense on EVD-68, DoD communication networks for Ebola crisis regions, new meningitis vaccine and more…

    Troops to be checked for chemical exposure in Iraq (NY Times)

    Aerosolized fungal infection from bats (GMU Pandora Report)

    EVD-68 cases fading, but more unexplained neuro illnesses (CIDRAP)

    Evaluation of border entry screening for infectious diseases in humans (EID Journal)

    FDA approves vaccine for a rare meningitis (NY Times)

    Ebola: Failures of imagination (Lanard and Sandman)

    The decision to publish an avian H7N1 gain-of-function experiment (mBio)

    Novel biosensor could allow rapid detection of Ebola virus (UC Santa Cruz)

    BARDA: The venture capital firm buried in the U.S. government (Marketplace)

    Drug that lost high-stakes political fight for funding now being used against Ebola (HP)

    Better staffing seen as crucial to Ebola treatment in Africa (NY Times)

    Light frequencies help sniff out deadly materials from a distance (HSNW)

    Ebola genome browser now online to aid researchers (HealthCanal)

    The bad, the worse and the over-interpreted (Virology Down Under)

    CSL-Novartis deal includes US cell-based flu vaccine plant (CIDRAP)

    Joint Chiefs chairman urges 21-day quarantine for troops in Ebola zone (NY Times)

    Mandatory Ebola quarantine is about politics, not public health (The Conversation)

    WHO updates Ebola PPE guidance for health providers (CIDRAP)

    Army providing communications backbone for Ebola response (Defense Systems)

    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNew Study Helping to Rewrite Ebola’s Family History
    Next Article DoD Seeks Help Manufacturing Ebola EZ1 Assays

    Related Stories

    Biodefense Headlines – 19 September 2023

    September 19, 2023

    Biodefense Headlines – 12 September 2023

    September 12, 2023

    Biodefense Headlines – 3 September 2023

    September 3, 2023

    Biodefense Headlines – 27 August 2023

    August 27, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy